ConductScience.org, home

Paper10951

Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.

Koch G. Br J Clin Pharmacol, 1976. Cited by 47 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise. Papers, record 10951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10951

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
2.82
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koch GG

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic alpha-AntagonistsMajor topic
Adrenergic beta-AntagonistsMajor topic
HemodynamicsMajor topic
HypertensionMajor topic
Physical ExertionMajor topic
Administration, Oral
Adult
Blood Pressure
Female
Follow-Up Studies
Humans
Labetalol
Male
Middle Aged
Pulse
Renin

Source PubMed

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
7,428,793Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7428793PubMed
7,093,100Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093100PubMed
7,082,539Rapid reduction of blood pressure with acute oral labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7082539PubMed
6,310,204Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.Klin Wochenschr1983https://conductscience.org/library/papers/6310204PubMed
6,124,265Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6124265PubMed
583,322Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.Br J Clin Pharmacol1979https://conductscience.org/library/papers/583322PubMed
526,408Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526408PubMed
526,397Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526397PubMed
385,023A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/385023PubMed
106,867Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.Br Heart J1979https://conductscience.org/library/papers/106867PubMed
26,446Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.Br J Pharmacol1978https://conductscience.org/library/papers/26446PubMed
25,757Labetalol: a review of its pharmacology and therapeutic use in hypertension.Drugs1978https://conductscience.org/library/papers/25757PubMed
25,186Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/25186PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10951

GET https://conductscience.org/api/papers/v1/10951/authors